DNA aneuploidy and low S-phase fraction as favourable prognostic signs in metastatic melanoma.

por Muhonen, T., Pyrhönen, S., Laasonen, A., Asko-Seljavaara, S., Franssila, K.
Publicado 1991

Comparison of benign and malignant follicular thyroid tumours by comparative genomic hybridization.

por Hemmer, S., Wasenius, V. M., Knuutila, S., Joensuu, H., Franssila, K.
Publicado 1998

Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer.

por Niskanen, E., Blomqvist, C., Franssila, K., Hietanen, P., Wasenius, V. M.
Publicado 1997

Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?

por Hietanen, P., Blomqvist, C., Wasenius, V. M., Niskanen, E., Franssila, K., Nordling, S.
Publicado 1995

The prognostic value of DNA-ploidy in colorectal carcinoma: a prospective study.

por Kouri, M., Pyrhönen, S., Mecklin, J. P., Järvinen, H., Laasonen, A., Franssila, K., Nordling, S.
Publicado 1990

Tumour growth rate and DNA flow cytometry parameters as prognostic factors in metastatic melanoma.

por Muhonen, T., Pyrhönen, S., Laasonen, A., Wasenius, V. M., Asko-Seljavaara, S., Franssila, K., Kangas, L.
Publicado 1992

A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer.

por Sjöström, J., Krajewski, S., Franssila, K., Niskanen, E., Wasenius, V. M., Nordling, S., Reed, J. C., Blomqvist, C.
Publicado 1998